Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Development to Delivery: A CDMO’s Guide to Strategic Scale-Up | Contract Pharma
Sponsored Content

Development to Delivery: A CDMO’s Guide to Strategic Scale-Up

Released By August Bioservices

Bringing a sterile injectable product from development to commercialization requires a seamless scale-up process—one that minimizes risk, optimizes efficiency, and ensures regulatory success. In this exclusive webinar, experts from August Bioservices will discuss the critical factors that make or break a successful scale-up, sharing insights from a CDMO’s unique perspective.

Our discussion will focus on three key perspectives:

  • Talent & Expertise: Scaling a business requires specialized expertise across multiple disciplines—from formulation development and process optimization to analytical testing and regulatory compliance. We will explore how the right talent at each phase of building a sterile injectable CDMO ensures that the right people are in the right roles at the right time, mitigating bottlenecks before they arise.
  • Equipment & Facility Readiness: Having the right infrastructure in place is crucial to scaling a CDMO. We’ll discuss how state-of-the-art manufacturing lines, flexible capacity, and facilities designed to meet global regulatory requirements play a role in accelerating scale-up while maintaining product quality and regulatory compliance.
  • Customer-Centric Approach: A CDMO is more than just a service provider, it’s a strategic partner. We’ll highlight why close collaboration with clients throughout the development and scale-up process is essential, ensuring alignment on goals, timelines, and quality expectations. From early-stage development through commercial launch, our team works as an extension of our clients’ teams, and that collaborative approach ultimately serves to de-risk the process and enable long-term program success.

Request more information from August Bioservices

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters